archive-au.com » AU » C » CSL.COM.AU

Total: 502

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • JESPECT®
    Products Complete Product List JESPECT Inactivated Japanese Encephalitis Vaccine JESPECT is indicated for active immunisation against Japanese Encephalitis JE virus for persons 18 years of age and older JESPECT should be considered for use in persons who plan to reside in or travel to areas where JE is endemic common or epidemic seasonal especially during the transmission season JESPECT is indicated for persons who work whith JE virus in laboratories and in industry This product is available only with a doctor s prescription Who is this information for This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals Consumer Medicine Information The Consumer Medicine Information CMI is a leaflet written for consumers The CMI contains information about the medicine including What this product is used for How it works Before and after the vaccination How this product is given Side effects Jespect Consumer Medicine Information PDF 0 09MB Product Information Product Information contains information to ensure the safe and effective use of a medicine This document is approved by the Therapeutic Goods Administration and made available by bioCSL for you if you are a qualified healthcare professional or consumer

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C/1253567371592/ProductDetail.htm (2014-01-05)
    Open archived version from archive

  • M-M-R® II
    Development Business Development Investors Corporate Responsibility Careers Newsroom Contact CSL Home Our Products Complete Product List M M R II Measles Mumps and Rubella Virus Vaccine Live MSD M M R II is indicated for simultaneous immunisation against measles mumps and rubella German measles This vaccine is available only from your doctor or immunisation clinic This product is available only with a doctor s prescription Who is this information for This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals Consumer Medicine Information The Consumer Medicine Information CMI is a leaflet written for consumers The CMI contains information about the medicine including What this product is used for How it works Before and after the vaccination How this product is given Side effects M M R II Consumer Medicine Information 40kb Product Information Product Information contains information to ensure the safe and effective use of a medicine This document is approved by the Therapeutic Goods Administration and made available by bioCSL for you if you are a qualified healthcare professional or consumer provided you have read the Consumer Medicine Information for the product want further information on the product

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C/1255929630518/ProductDetail.htm (2014-01-05)
    Open archived version from archive

  • Menjugate
    Australia and is intended for people who have been prescribed this product or health care professionals Consumer Medicine Information The Consumer Medicine Information CMI is a leaflet written for consumers The CMI contains information about the medicine including What this product is used for How it works Before and after the vaccination How this product is given Side effects Menjugate Consumer Medicine Information PDF 0 05MB Product Information Product Information

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C/1196562633361/ProductDetail.htm (2014-01-05)
    Open archived version from archive

  • Menveo®
    Contact CSL Home Our Products Complete Product List Menveo Vaccine for Meningococcal Groups A C W 135 and Y oligosaccharide CRM197 conjugate vaccine Menveo is indicated for active immunisation of adolescents from 11 years of age and adults to prevent invasive disease caused by Neisseria meningitidis serogroups A C W 135 and Y The use of this vaccine should be in accordance with official recommendations This product is available only with a doctor s prescription Who is this information for This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals Consumer Medicine Information The Consumer Medicine Information CMI is a leaflet written for consumers The CMI contains information about the medicine including What this product is used for How it works Before and after the vaccination How this product is given Side effects Menveo Consumer Medicine Information 0 06Mb Product Information Product Information contains information to ensure the safe and effective use of a medicine This document is approved by the Therapeutic Goods Administration and made available by bioCSL for you if you are a qualified healthcare professional or consumer provided you have read the Consumer Medicine Information for

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C/1255925416892/ProductDetail.htm (2014-01-05)
    Open archived version from archive

  • Pneumovax 23
    is intended for people who have been prescribed this product or health care professionals Consumer Medicine Information The Consumer Medicine Information CMI is a leaflet written for consumers The CMI contains information about the medicine including What this product is used for How it works Before and after the vaccination How this product is given Side effects Pneumovax 23 Consumer Medicine Information PDF 0 91MB Product Information Product Information contains

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C/1196562642806/ProductDetail.htm (2014-01-05)
    Open archived version from archive

  • Q-VAX
    information for This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals Consumer Medicine Information The Consumer Medicine Information CMI is a leaflet written for consumers The CMI contains information about the medicine including What this product is used for How it works Before and after the vaccination How this product is given Side effects Q Vax Consumer Medicine

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C/1196562634452/ProductDetail.htm (2014-01-05)
    Open archived version from archive

  • Rabipur
    for This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals Consumer Medicine Information The Consumer Medicine Information CMI is a leaflet written for consumers The CMI contains information about the medicine including What this product is used for How it works Before and after the vaccination How this product is given Side effects Rabipur Consumer Medicine Information PDF

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C/1196562642859/ProductDetail.htm (2014-01-05)
    Open archived version from archive

  • RotaTeq®
    Research and Development Business Development Investors Corporate Responsibility Careers Newsroom Contact CSL Home Our Products Complete Product List RotaTeq Rotavirus Vaccine Live Oral Pentavalent RotaTeq is a viral vaccine that is used in infants for the prevention of gastroenteritis diarrhoea and vomiting caused by rotavirus infection This vaccine is available only from your doctor or immunisation clinic This product is available only with a doctor s prescription Who is this information for This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals Consumer Medicine Information The Consumer Medicine Information CMI is a leaflet written for consumers The CMI contains information about the medicine including What this product is used for How it works Before and after the vaccination How this product is given Side effects RotaTeq Consumer Medicine Information PDF 0 05MB Product Information Product Information contains information to ensure the safe and effective use of a medicine This document is approved by the Therapeutic Goods Administration and made available by bioCSL for you if you are a qualified healthcare professional or consumer provided you have read the Consumer Medicine Information for the product want further information on the

    Original URL path: http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C/1196562634677/ProductDetail.htm (2014-01-05)
    Open archived version from archive